Stroke survivors: new hope for blood pressure control?

NCT ID NCT04760717

First seen Apr 04, 2026 · Last updated May 16, 2026 · Updated 4 times

Summary

This study tests whether adding the drug spironolactone to standard blood pressure treatment is more effective than standard treatment alone for stroke survivors. About 160 adults who had a stroke will participate. The main goal is to see if spironolactone leads to lower home blood pressure readings after three months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • Temple University Hospital

    Philadelphia, Pennsylvania, 19140, United States

  • University of Texas Health Science Center at Houston

    Houston, Texas, 77030, United States

  • Wake Forest Baptist Health

    Winston-Salem, North Carolina, 27157, United States

  • Yale New Haven Hospital

    New Haven, Connecticut, 06512, United States

Conditions

Explore the condition pages connected to this study.